SCHEMBL7938779

SCHEMBL7938779

CCCN(CCC)C1CCc2cccc(NC(=O)S)c2C1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.62
HTR7 P34969 3/20 0.62
DRD2 P14416 2/20 0.62
HTR1D P28221 2/20 0.62
DRD3 P35462 2/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2D6 P10635 1/20 0.62
TSHR P16473 1/20 0.62
HTR1B P28222 1/20 0.62
HTR2A P28223 1/20 0.62
HTR2C P28335 1/20 0.62
ADRA1A P35348 1/20 0.62
ADRA1B P35368 1/20 0.62
HTR2B P41595 1/20 0.62
HTR5A P47898 1/20 0.62
BLM P54132 1/20 0.61
ALDH1A1 P00352 1/20 0.61
LMNA P02545 1/20 0.61
PMP22 Q01453 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9759545 0.89 HTR1A (0.64) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL10994014 0.84 HTR1A (0.57) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL9758514 0.84 HTR1A (0.58) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL10994018 0.84 HTR1A (0.57) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL9187345 0.81 HTR1A (0.62) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7330393 0.80 DRD2 (0.64) HTR1AHTR7DRD2DRD3
SCHEMBL8904245 0.79 HTR1A (0.70) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7329114 0.79 DRD2 (0.62) HTR1AHTR7DRD2DRD3
Hydrochloric Acid SCHEMBL7328457 0.79 DRD2 (0.62) HTR1AHTR7DRD2DRD3
Hydrochloric Acid SCHEMBL7331395 0.79 DRD2 (0.62) HTR1AHTR7DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6331636-B1 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, DIABETES, HYPERTENSION, IMPOTENCY, APPETITE CONTROL THE UPJOHN COMPANY 2001-12-18 US disclosed
US-5545755-A USEFUL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS, HYPERTENSION, DIABETES, SEXUAL IMPOTENCY AND TO CONTROL APPETITE THE UPJOHN COMPANY (US) 1996-08-13 US disclosed
EP-0476016-A1 THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 1992-03-25 EP disclosed
WO-1990015047-A1 THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed